𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors

✍ Scribed by Deborah B. Crom; Donna K. Chathaway; Elizabeth A. Tolley; Raymond K. Mulhern; Melissa M. Hudson


Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
164 KB
Volume
83
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


We have examined the influence of selected factors (gender, marital status, socio-economic status, co-morbid conditions, access to medical care, age at diagnosis, intensity of therapy and time since diagnosis) on subsequent health status and health-related quality of life (HRQL) of long-term survivors of pediatric solid tumors. Two hundred and twenty individuals who had survived a pediatric solid tumor 15 years or longer completed telephone and written assessments of their current status. Health status was assessed using the Late Effects of Normal Tissues toxicity scale. HRQL was investigated using the Ferrans and Powers Quality of Life Index-Cancer (QLIC) and the EORTC Quality of Life Questionnaire C30 (QLQ-C30). Results indicated that health status and HRQL were better in survivors treated with lowintensity therapy. One hundred and thirty respondents (59.1%) reported at least 1 serious toxicity. Dyspnea and fatigue were commonly reported in survivors of Hodgkin's disease. Correlational analyses showed that predictors of health status included socio-economic status, marital status and the presence of co-morbid factors. Mean HRQL scores for the 4 domains of the Ferrans and Powers QLIC and the functional scales of the EORTC QLQ-C30 indicated that most of the survivors were experiencing moderately good to excellent HRQL. One-third of survivors reported that their history of cancer had an adverse impact on their current financial status. Prediction models constructed for 3 of the domains from the 2 HRQL instruments are presented (health and functioning, global HRQL and financial impact). Within these 3 models, consistent predictors of HRQL outcomes included health status, presence of dyspnea or pain, marital status and socio-economic status.


πŸ“œ SIMILAR VOLUMES


Assessment of health status and health-r
✍ Charmaine S. Van Schaik; Ronald D. Barr; Sonja Depauw; William Furlong; David Fe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 111 KB πŸ‘ 2 views

Although the great majority of children with Hodgkin's disease survive with modern treatment strategies, the list of late sequelae is long, yet there is no published information on the comprehensive health status and health-related quality of life (HRQL) in this population. In the experience of a si

Health-related quality of life in pediat
✍ Susan K. Parsons; Sarah E. Barlow; Sheryl L. Levy; Stacey E. Supran; Sherrie H. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 115 KB πŸ‘ 2 views

Historically, health-related quality of life (HRQL) assessment in pediatrics, including the few validated instruments in pediatric oncology, has been based on proxy reporting, relying primarily on parental assessment. Children have been deemed incapable of providing consistent and reliable informati

Total knee replacement and health-relate
✍ NΓΊΓ±ez, Montserrat ;Lozano, Luis ;NΓΊΓ±ez, Esther ;Segur, Josep M. ;Sastre, Sergi ; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 131 KB

## Abstract ## Objective To evaluate health‐related quality of life (HRQOL) in patients with osteoarthritis undergoing total knee replacement (TKR); identify the influence of sociodemographic, clinical, intraoperative, and postoperative variables on HRQOL; and determine patient perceptions at 7 ye

The Pediatric Cancer Quality of Life Inv
✍ Michael Seid; James W. Varni; Cheryl A. Rode; Ernest R. Katz πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 89 KB πŸ‘ 2 views

Measurement of pediatric cancer patients' health-related quality of life (HRQL) in phase III randomized, controlled clinical trials is being recognized increasingly as an essential component in evaluating the comprehensive health outcomes of modern anti-neoplastic treatment protocols. Use of a brief